Covidien Announces Enrollment of First Patient in SWIFT PRIME Acute Ischemic Stroke Study

By: Benzinga
Covidien (NYSE: COV ) today announced the launch of a new study, SWIFT PRIME, which enrolled its first patient at the University at Buffalo. The new multi-center,
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.